Ibandronate sodium, sold under the brand name Boniva; calcitonin-salmon, sold under the brand names Fortical and Miacalcin; denosumab, sold under the name Prolia; and teriparatide parathyroid hormone, sold under the brand name Forteo, are injectable drugs to treat osteoporosis, according to the National Osteoporosis Foundation. The first three are antiresorptive medicines that slow bone loss, while teriparatide is an anabolic drug that increases bone formation.Continue Reading
Ibandronate sodium prevents and treats osteoporosis in postmenopausal women, explains the National Osteoporosis Foundation. Women receive a 3 milligram intravenous injection of the drug every three months. Alternatively, they can take the medication in the form of a 150 milligram pill once a month.
Calcitonin-salmon treats osteoporosis in women who have been in menopause for at least five years, advises the National Osteoporosis Foundation. Women self-administer the injection subcutaneously or intramuscularly in the dose prescribed by their physicians once a day or every other day, notes MedlinePlus. The medication is available as a nasal spray, and an oral form of the drug is under development as of 2015, explains the National Osteoporosis Foundation.
The FDA has approved denosumab to treat osteoporosis in postmenopausal women at high risk of incurring fractures, states the National Osteoporosis Foundation. It also received approval to increase bone mass in men with osteoporosis who are at high risk of incurring fractures. A health care professional administers the injection every six months.
Teriparatide treats osteoporosis in postmenopausal women and in men who are at high risk of incurring a bone fracture, according to the National Osteoporosis Foundation. It is available in a preloaded pen that contains one month of medication that the patient self-administers daily for no more than two years.Learn more about Medications & Vitamins